Vern Schramm Net Worth

Vern Schramm biography

Dr. Vern Lee Schramm Ph.D. serves as Independent Director of the Company. Dr. Schramm has served as Professor of the Albert Einstein College of Medicine since 1987 and Chair of the Department of Biochemistry from 1987 to 2015, and was awarded the Ruth Merns Endowed Chair in Biochemistry. His fields of interest include enzymatic transition state analysis, transition state inhibitor design, biological targets for inhibitor design, and mechanisms of N-ribosyltransferases. Dr. Schramm was elected to the National Academy of Sciences in 2007, and served as the Associate Editor for the Journal of the American Chemical Society between 2003 to 2012. A frequent lecturer and presenter in topics related to chemical biology, Dr. Schramm has been a consultant and advisor to Pico Pharmaceuticals, Metabolon Inc., Sirtris Pharmaceuticals, and BioCryst Pharmaceuticals. Dr. Schramm obtained his BS in Bacteriology with an emphasis in chemistry from South Dakota State College and holds a Master’s Degree in Nutrition with an emphasis in biochemistry from Harvard University, a Ph.D. in Mechanism of Enzyme Action from the Australian National University and completed his postdoctoral training at NASA Ames Research Center, Biological Sciences, with an NSF-NRC fellowship.

How old is Vern Schramm?

Vern Schramm is 78, he's been the Independent Director of AzurRx BioPharma Inc since 2017. There are no older and 8 younger executives at AzurRx BioPharma Inc.

What's Vern Schramm's mailing address?

Vern's mailing address filed with the SEC is 760 Parkside Ave #304, Brooklyn, NY 11226, USA.

Insiders trading at AzurRx BioPharma Inc

Over the last 8 years, insiders at AzurRx BioPharma Inc have traded over $510,400 worth of AzurRx BioPharma Inc stock and bought 335,700 units worth $727,436 . The most active insiders traders include Charles J Casamento, Edmund Burke Jr. Ross und Partners Llcbalk Matthew Pe.... On average, AzurRx BioPharma Inc executives and independent directors trade stock every 82 days with the average trade being worth of $262,052. The most recent stock trade was executed by Johan M. Spoor on 28 December 2018, trading 38,583 units of AZRX stock currently worth $50,158.

What does AzurRx BioPharma Inc do?

AzurRx BioPharma Inc executives and stock owners

AzurRx BioPharma Inc executives and other stock owners filed with the SEC include:

• James R. Sapirstein R.Ph., M.B.A.,
  CEO, Pres & Non-Independent Director
• James Pennington,
  Chief Medical Officer
• James Sapirstein,
  President, Chief Executive Officer, Director
• Alastair Riddell,
  Independent Director
• Edward Borkowski,
  Independent Chairman of the Board
• Vern Schramm,
  Independent Director
• Charles Casamento,
  Independent Director
• Gregory Oakes,
  Independent Director
• Daniel Schneiderman,
  Chief Financial Officer
• Martin Krusin M.B.A.,
  Sr. VP of Corp. Devel.
• Johan M. Spoor,
  
• Partners Llcbalk Matthew Pe...,
  
• Edmund Burke Jr. Ross,
  
• Maged Shenouda,
  CHIEF FINANCIAL OFFICER
• Daniel Dupret,
  CHIEF SCIENTIFIC OFFICER
• Mary Theresa Coelho,